Arterial Cannula Market (By Application: Cardiopulmonary Bypass Surgery, Extracorporeal Membrane Pulmonary Oxygenation; By Size; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

The global arterial cannula market is expected to experience exponential growth over the forecast period majorly due to the increasing prevalence of cardiovascular diseases. For instance, according to the American Heart Association, nearly half of U.S. adults have some type of cardiovascular disease in 2019. Moreover, according to CDC, in 2020, about 20.1 million adults aged 20 and over had coronary artery diseases in the U.S., which is about 7.2% of the country’s total population.

In addition, a favorable reimbursement scenario for cardiac interventions is also expected to boost the growth of the arterial cannula market over the forecast period. For instance, in recent years the Centers for Medicare & Medicaid Services expanded ASC coverage for cardiac interventional procedures which includes endovenous ablation, catheterization procedures, and pacemaker placements. This has resulted in a higher number of patients now opting for these procedures in the ambulatory surgical center. This, in turn, is leading to a higher number of people undergoing cardiac surgeries which is expected to have a huge positive impact on the market and represent lucrative growth opportunities over the forecast period.

Based on application, the cardiopulmonary bypass surgery segment is expected to experience maximum growth over the forecast period. According to a research article published in 2018 by National Center for Biotechnology Information, coronary artery bypass surgery is still the most commonly performed cardiac surgery procedure worldwide, representing annual volumes of approximately 200,000 isolated cases in the US and an average incidence rate of 62 per 100,000 inhabitants in western European countries.This is further expected to increase over the forecast period due to the rising prevalence of cardiac diseases that requires cardiopulmonary bypass surgery.

On the basis of size, the 20-22 Fr is expected to dominate the market due to increased usage of these cannulas in extracorporeal membrane oxygenation which holds the highest market share in the arterial cannula market in terms of application.

Key Players

  • Medtronic, plc.
  • LivaNova plc
  • Edward Lifesciences 
  • Getinge AB
  • Fresenius Medical Care 
  • BD
  • Nipro Corporation
  • Andocor
  • Freelife Medical GmbH
  • Surgical Holdings
  • Kangxin Medical

Market Segmentation

  • By Application
    • Cardiopulmonary bypass surgery
    • Extracorporeal Membrane Pulmonary Oxygenation (ECMO)
    • Others
  • By Size
    • 14-16 Fr
    • 17-19 Fr
    • 20-22 Fr
    • 23-25 Fr
    • 26-28 Fr
    • 29- 31 Fr
    • 32-34 Fr
    • 35-36 Fr
  • By End-use
    • Hospital
    • Ambulatory Surgical Centers
    • Others
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East & Africa

Report Detail

Proceed To Buy

USD 3500
USD 7000